Voss Capital’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
PP
PF
NTCM
CI
Voss Capital's CLBT Position: Q2 2026 in Review
Voss Capital increased its Cellebrite (CLBT) stake by 18% in Q2 2026, buying an estimated $23.4M and bringing the position to 11,441,874 shares worth $167M. The position accounts for 7.76% of the portfolio, ranked #3.
Voss Capital first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Voss Capital held 11,441,874 shares of Cellebrite worth $167M as of Q2 2026.
- Voss Capital bought 1,766,874 Cellebrite shares in Q2 2026, an estimated $23.4M.
- Cellebrite made up 7.76% of Voss Capital's portfolio in Q2 2026, its #3 holding.
- Voss Capital first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Voss Capital's 13F filing for Q2 2026, filed 14 Aug 2026.